Development of a novel tumor-targeting and tumor-penetrating nanosystem for breast cancer therapy
Ended Project Grant Awarded Last action
- Award ID
- W81XWH2010122
- Recipient
-
Endurx Pharmaceuticals Inc. UEI KWKNEAQPAK43
- Awarding agency
-
Defense Health Agency
Department of Defense
- Obligated
- $1,412,302
Award facts
- Assistance listing
- 12.420 Military Medical Research and Development
- Completion date
- Originally
- Place of performance
- Tucson, AZ 85741, USA
Award details come from USAspending.gov.
Transactions
| Action | Obligated | Date |
|---|---|---|
| Amendment | $0 | |
| Amendment | $0 | |
| Amendment | $0 | |
| Original award | $1,412,302 |
Quick answers
Who received award W81XWH2010122?
W81XWH2010122 was awarded to Endurx Pharmaceuticals Inc. by Defense Health Agency (Department of Defense) on March 1, 2020.
How much is award W81XWH2010122 worth?
$1,412,302 has been obligated on W81XWH2010122.
On GovTribe
See this award's full record
- Every transaction and subaward
- The recipient's other awards and teaming partners
- Similar grant awards
- Ask GovTribe AI about this award